Alliance Pharma PLC
LSE:APH
Intrinsic Value
The intrinsic value of one APH stock under the Base Case scenario is 101.71 GBX. Compared to the current market price of 64.2 GBX, Alliance Pharma PLC is Undervalued by 37%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Alliance Pharma PLC
Fundamental Analysis

Revenue & Expenses Breakdown
Alliance Pharma PLC
Balance Sheet Decomposition
Alliance Pharma PLC
Current Assets | 104.3m |
Cash & Short-Term Investments | 32.4m |
Receivables | 49.4m |
Other Current Assets | 22.6m |
Non-Current Assets | 264.8m |
PP&E | 5.4m |
Intangibles | 253.6m |
Other Non-Current Assets | 5.8m |
Free Cash Flow Analysis
Alliance Pharma PLC
GBP | |
Free Cash Flow | GBP |
Earnings Waterfall
Alliance Pharma PLC
Revenue
|
178.8m
GBP
|
Cost of Revenue
|
-69.6m
GBP
|
Gross Profit
|
109.3m
GBP
|
Operating Expenses
|
-75.9m
GBP
|
Operating Income
|
33.4m
GBP
|
Other Expenses
|
-44.2m
GBP
|
Net Income
|
-10.7m
GBP
|
APH Profitability Score
Profitability Due Diligence
Alliance Pharma PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Alliance Pharma PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
APH Solvency Score
Solvency Due Diligence
Alliance Pharma PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Score
Alliance Pharma PLC's solvency score is 49/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APH Price Targets Summary
Alliance Pharma PLC
According to Wall Street analysts, the average 1-year price target for APH is 67.61 GBX with a low forecast of 62.62 GBX and a high forecast of 89.25 GBX.
Dividends
Current shareholder yield for APH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one APH stock under the Base Case scenario is 101.71 GBX.
Compared to the current market price of 64.2 GBX, Alliance Pharma PLC is Undervalued by 37%.